Reduced Neuronal Activity is One of the Major Hallmarks of Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-60680-9_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Peripheral nerve stimulation in Alzheimer's disease].

  1997cited by this paper
• APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology.

  1996cited by this paper
• Expression of APP in transgenic mice: a comparison of neuron-specific promoters.

  1996cited by this paper
• Combined Study of Cerebral Glucose Metabolism and [11C]Methionine Accumulation in Probable Alzheimer's Disease Using Positron Emission Tomography

  1996cited by this paper
• Lack of β-Amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations

  1996cited by this paper
• Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

  1996cited by this paper
• Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity.

  1995cited by this paper
• Decreased Activity of Hippocampal Neurons in Alzheimer's Disease Is Not Related to the Presence of Neurofibrillary Tangles

  1995cited by this paper
• No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease.

  1995cited by this paper
• Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer's disease.

  1995cited by this paper
• A familial Alzheimer's disease locus on chromosome 1

  1995cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus.

  1995cited by this paper
• Peripheral nerve stimulation in Alzheimer's disease; A meta-analysis

  1995cited by this paper
• Increased light intensity prevents the age related loss of vasopressin-expressing neurons in the rat suprachiasmatic nucleus.

  1995cited by this paper
• Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

  1995cited by this paper
• Effects of simultaneously applied short-term transcutaneous electrical nerve stimulation and tactile stimulation on memory and affective behaviour of patients with probable Alzheimer's disease.

  1995cited by this paper
• Human neurons that constitutively secrete A beta do not induce Alzheimer's disease pathology following transplantation and long-term survival in the rodent brain.

  1995cited by this paper
• Functional Alterations in Alzheimer's Disease: Selective Loss of Mitochondrial-encoded Cytochrome Oxidase mRNA in the Hippocampal Formation

  1994cited by this paper
• Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia

  1994cited by this paper
• Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital.

  1994cited by this paper
• No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type.

  1994cited by this paper
• Arguments for and against the primary amyloid local induction hypothesis on the pathogenesis of Alzheimer's disease

  1994cited by this paper
• Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease.

  1994cited by this paper
• Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas.

  1994cited by this paper
• Brain Glucose Metabolism in Alzheimer's Disease

  1994cited by this paper
• Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease.

  1994cited by this paper
• Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus.

  1994cited by this paper
• Alzheimer's Disease: A Central Role for Amyloid

  1994cited by this paper
• Activation of Vasopressin Neurons in Aging and Alzheimer's Disease

  1994cited by this paper
• Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

  1993cited by this paper
• Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type.

  1993cited by this paper
• Alterations in Glucose Metabolism in Patients with Alzheimer's Disease

  1993cited by this paper
• Effect of light intensity on diurnal sleep-wake distribution in young and old rats.

  1993cited by this paper
• Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.

  1993cited by this paper
• The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients.

  1993cited by this paper
• Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study.

  1993cited by this paper
• Molecular pathology of Alzheimer's disease.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians.

  1993cited by this paper
• The spatial patterns of plaques and tangles in Alzheimer's disease do not support the 'cascade hypothesis'.

  1993cited by this paper
• Functional Alterations in Alzheimer's Disease: Diminution of Cytochrome Oxidase in the Hippocampal Formation

  1993cited by this paper
• Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease.

  1993cited by this paper
• Disease‐specific patterns of locus coeruleus cell loss

  1992cited by this paper
• Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3

  1992cited by this paper
• A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene

  1992cited by this paper
• Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14

  1992cited by this paper
• In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment

  1992cited by this paper
• Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid.

  1992cited by this paper
• Cerebral glucose metabolism in Parkinson's disease with and without dementia.

  1992cited by this paper
• The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain.

  1992cited by this paper
• Age-associated inclusions in normal and transgenic mouse brain.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain.

  1992cited by this paper
• τ and ubiquitin in the human hypothalamus in aging and Alzheimer's disease

  1992cited by this paper
• The hypothalamic lateral tuberal nucleus: normal anatomy and changes in neurological diseases.

  1992cited by this paper
• Alzheimer's disease: Are cellular neurofibrillary tangles linked to beta/A4 formation at the projection sites?

  1992cited by this paper
• Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease.

  1992cited by this paper
• Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

  1991cited by this paper
• Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it".

  1991cited by this paper
• Formation of β-amyloid protein deposits in brains of transgenic mice

  1991cited by this paper
• Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein

  1991cited by this paper
• The hypothalamic lateral tuberal nucleus in Alzheimer's disease

  1991cited by this paper
• Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment.

  1991cited by this paper
• The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.

  1991cited by this paper
• Deposits of amyloid beta protein in the central nervous system of transgenic mice.

  1991cited by this paper
• Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging.

  1991cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• Alzheimer patients: preamyloid deposits are immunoreactive with antibodies to extracellular domains of the amyloid precursor protein.

  1991cited by this paper
• Molecular features of hypothalamic plaques in Alzheimer's disease.

  1991cited by this paper
• Intellectual functioning in treated Wilson's disease

  1991cited by this paper
• Neuritic pathology and dementia in alzheimer's disease

  1991cited by this paper
• Deposits of amyloid β protein in the central nervous system of transgenic mice

  1991cited by this paper
• Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.

  1990cited by this paper
• Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease.

  1990cited by this paper
• Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person

  1990cited by this paper
• The occult aftermath of boxing.

  1990cited by this paper
• The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease.

  1990cited by this paper
• Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.

  1989cited by this paper
• Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression

  1989cited by this paper
• A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition

  1989cited by this paper
• The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes.

  1989cited by this paper
• Stability of cell size and nucleolar size in tangle-bearing neurons of the hippocampus in Alzheimer's disease.

  1989cited by this paper
• Alzheimer's disease: amyloid plaques in the cerebellum

  1989cited by this paper
• Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques

  1989cited by this paper
• Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease.

  1989cited by this paper
• The basal nucleus of Meynert revised: the nerve cell number decreases with age.

  1989cited by this paper
• Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.

  1989cited by this paper
• Clinico‐pathologic studies in dementia

  1988cited by this paper
• Heterogeneous anterior‐posterior metabolic patterns in dementia of the Alzheimer type

  1988cited by this paper
• Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease.

  1988cited by this paper
• Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

  1988cited by this paper
• A4 amyloid protein deposition and the diagnosis of Alzheimer's disease

  1988cited by this paper
• Neuronal RNA in relation to alz‐50 immunoreactivity in alzheimer's disease

  1988cited by this paper
• Sexual differentiation of the human hypothalamus: ontogeny of the sexually dimorphic nucleus of the preoptic area.

  1988cited by this paper
• Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

  1988cited by this paper
• Does amyloid precede paired helical filaments in the senile plaque? A study of 15 cases with graded intellectual status in aging and Alzheimer disease.

  1988cited by this paper
• Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease

  1987cited by this paper
• Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles

  1987cited by this paper

• Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.

  2008cites this paper
• Soluble oligomeric A&bgr; disrupts the protein kinase C signaling pathway

  2004cites this paper
• Selective neuronal degeneration induced by soluble oligomeric amyloid beta‐protein

  2003cites this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cites this paper
• Non‐fibrillar β‐amyloid exerts toxic effect on neuronal cells

  2001cites this paper